432 filings
Page 2 of 22
S-8 POS
i116ihyv cns
24 Mar 23
Registration of securities for employees (post-effective amendment)
8:34am
S-8 POS
mz3r 8xiatdd0u1m8h3
24 Mar 23
Registration of securities for employees (post-effective amendment)
8:33am
S-8 POS
m6myeku albqva
24 Mar 23
Registration of securities for employees (post-effective amendment)
8:32am
S-8 POS
fxwt9di7qrm9jg57
24 Mar 23
Registration of securities for employees (post-effective amendment)
8:29am
S-8 POS
0yh0mk4tdq
24 Mar 23
Registration of securities for employees (post-effective amendment)
8:27am
S-8 POS
cr0ir0haac
24 Mar 23
Registration of securities for employees (post-effective amendment)
8:20am
8-K
v51iekmr6a
22 Mar 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9:00am
8-K
0sqfc2nl
15 Mar 23
Entry into a Material Definitive Agreement
6:05am
8-K
whgneqirsvxxi362k
13 Mar 23
Other Events
8:00am
8-K
61s qoepv
3 Feb 23
Cost Associated with Exit or Disposal Activities
6:02am
8-K
qwyjvry
5 Jan 23
Entry into a Material Definitive Agreement
9:26am
8-K
kf1tmotm2dkibq9p ko
4 Jan 23
Vyant Bio Engages LifeSci Capital to Explore Strategic Alternatives
4:13pm
8-K
0iws zdtx
19 Dec 22
Amendments to Articles of Incorporation or Bylaws
5:29pm
8-K
apaxeexfrhzmhn
5 Dec 22
Departure of Directors or Certain Officers
5:13pm
8-K
sej2a6k0 vavu
16 Nov 22
Vyant Bio Presents Key Takeaways from Platform and Poster Presentations at Neuroscience 2022 Hosted by the Society for Neuroscience
5:26pm
8-K
x28b60fzc wnrpv6uke1
16 Nov 22
Other Events
4:59pm
8-K
pywu8t4f w1p062g
3 Nov 22
Reaction Biology and Vyant Bio Announce Closing of Definitive Agreement to Acquire U.S. Operations of Vyant Bio, Inc. Subsidiary
9:10am
8-K
tpzykjc cqn
2 Nov 22
Material Modifications to Rights of Security Holders
8:00am